UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


      Date of Report (Date of Earliest Event Reported): September 13, 2004


                                  XTRANA, INC.
             (Exact name of registrant as specified in its charter)


         DELAWARE                     1-14257                    58-1729436
(State or other jurisdiction       (Commission               (I.R.S. Employer
    of incorporation)               File Number)             Identification No.)


                                  P.O. BOX 668
                             SEDALIA, COLORADO 80135
                (Address of Principal Executive Offices/Zip Code)


                                 (303) 466-4424
              (Registrant's telephone number, including area code)


         Check the  appropriate  box below if the Form 8-K filing is intended to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (SEE General Instruction A.2. below):

         |_|      Written   communications   pursuant  to  Rule  425  under  the
                  Securities Act (17 CFR 230.425)

         |_|      Soliciting material pursuant to Rule 14a-12 under the Exchange
                  Act (17 CFR 240.14a-12)

         |_|      Pre-commencement  communications  pursuant  to  Rule  14d-2(b)
                  under the Exchange ct (17 CFR 240.14d-2(B))

         |_|      Pre-commencement  communications  pursuant  to Rule  13e-4(c))
                  under the Exchange Act (17 CFR 240.13e-4c))





ITEM 8 - OTHER EVENTS

         TERMINATION OF MERGER DISCUSSIONS WITH ADUROMED CORPORATION

         On September 13, 2004,  Xtrana,  Inc. issued a press release announcing
that  it had  terminated  discussions  with  Aduromed  Corporation  regarding  a
potential merger or other business  combination.  A copy of the press release is
attached  to this  Form  8-K as  Exhibit  99.1  and is  incorporated  herein  by
reference.

ITEM 9.01 - FINANCIAL STATEMENTS AND EXHIBITS

         (a)      Financial Statements of business acquired.

                  Not applicable.

         (b)      Pro Forma Financial Information.

                  Not applicable.

         (c)      Exhibits.

                  The following exhibits are filed herewith:

                  EXHIBIT
                  NUMBER   DESCRIPTION
                  -------  -----------

                  99.1     Press Release dated September 13, 2004,  published by
                           Xtrana, Inc.


                                       2



                                    SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                        XTRANA, INC.



Date:    September 14, 2004             By:      /S/ JAMES CHAMBERLAIN
                                                 -------------------------------
                                                 James Chamberlain
                                                 Chief Executive Officer


                                       3



                                  EXHIBIT INDEX

EXHIBIT
NUMBER     DESCRIPTION
-------    ------------

99.1       Press Release dated September 13, 2004, published by Xtrana, Inc.


                                       4